Li Li And His Wife: The "Bait" Incident Has Made The New Richest Man.

Hai Pu Rui, a company that makes the economy unfamiliar, has become the focus of the capital market and even the whole society overnight because of the myth of making a fortune in the gem.

Li Li and Li Tan, a couple who were strangers to the outside world, had a total stake of 290 million shares and had reached 42 billion 600 million yuan. They were exposed to the spotlight in the media and become the new richest in the mainland of China.

When Li Li was in the road show, he regrets that he has become the new richest man. "All this is mainly to catch up with the great era".

However, there is also a view that rather than catching up with the great times, Li Li has hit the Universiade.

If there is no "bait" incident, he will not take off in 2009.

The leap forward growth in 2009, coupled with the current high valuation of gem, has made him create a new market value myth.

However, the overvalued value is based on the leap forward growth in 2009, and such growth will continue to be a big question mark.

If the high growth rate is not sustainable, it is difficult to withstand the test of the market because of the high value on the basis of high growth.

Classmate of Chemistry Department of Sichuan University

Li Li and Li Tan were born in 1964. They entered the Department of chemistry in Sichuan University in 1983 and graduated in the same year in 1987.

After graduation, Li Li went to work in Chengdu meat joint factory, while Li Tan worked in the Education Department of Anhui petrochemical industry hall.

According to the teacher of Chemistry Department of Sichuan University, Li Li and Li Tan studied hard and had excellent character in school. The two should have established love relationship in University.

In the prospectus, he pointed out that the core technology of the company is "heparin sodium material extraction and purification technology", which was developed by Li Li personally in the mid and late 80s of last century. After years of R & D and production practice, the company has been developing and improving.

"When I was a student, Li Li had been in this field (referring to heparin sodium)," he said. "In the past 25 years, I have been working most of the time besides sleeping and eating."

Obviously, Li Li has devoted all his energies to heparin since his college days.

After graduating from college, Li Li entered the meat factory in Chengdu. What work was he engaged in?

According to the prospectus, in October 1992, Chongqing Tongda Biological Products Co., Ltd., served as chief engineer, chairman and general manager, and Li Tan entered Chongqing in July 1992 and served as deputy chief engineer and deputy general manager.

Why can a worker in a meat factory become chairman of Chongqing Tongda company? The industrial and commercial registration materials reveal the mystery: Chongqing Tongda was founded in 1990, and the legal representative is Li Li.

That is to say, Li Tan and Li Li entered the Tongda in 1992, which is entirely logical.

Although Li Li and his wife did not know the details of entrepreneurship at this stage, they are obviously not as dazzling as they are today.

According to Tang Liangping, chairman of Chongqing's capital pharmaceutical company, Li Li also found him around 2000. He hoped that the two sides would cooperate to provide the factory and equipment for the pharmaceutical industry, and Li Li produced technology and raw materials to produce heparin sodium.

However, because Tang Liangping was not optimistic about the prospect of heparin sodium, cooperation did not take place.

This detail also shows that Li Li's career at that time was not smooth sailing.

In 1998, Li Li and his wife moved to Shenzhen and established the Shenzhen Hai Rui Industrial Company. They still operate heparin sodium raw material production.

Chongqing Tongda was cancelled in 2008.

Take advantage of the "bait" incident to achieve soaring

Heparin has many physiological functions, such as anticoagulation, anti-inflammatory, anti-virus, anticancer, blood lipid regulation and so on.

Before 1990s, western countries mainly extracted heparin from bovine intestinal mucosa.

But with the prevalence of "mad cow disease" in the cattle raising countries in Europe in early 90s, Europeans were worried about the safety of heparin extracted from bovine intestines. In the later years, European heparin producers no longer extracted heparin from cattle intestines and switched to pig intestines.

China is the world's largest pig breeding country, and China's pig population accounts for about half of the world's hog.

This provides a solid foundation for the extraction of heparin sodium from pig intestines.

From the end of 1980s to the beginning of 90s, hundreds of meat factories in the country (because of sufficient pig raw materials) were on the way to produce heparin sodium, and competing for export. In recent years, the export of heparin has been maintained at around 100 tons per year.

In 2007, the total amount of heparin export in China was US $137 million.

In this large and favorable environment, heparin sodium business in Shenzhen has maintained rapid growth and has become the first largest exporter of heparin in China.

However, it is the bait incident that really brings about the development of Hai Rui.

In February 28, 2008, American Baxter medical company officially announced the recall of a large number of heparin products.

On the day the US announced the recall, the US Food and Drug Administration (FDA) issued a statement saying it had received a total of 448 reports of various side effects associated with heparin.

Of the 21 reports that FDA has received for various reasons, 12 have used Baxter products.

From mid December 2007 to January 2008, American bait said that about 350 people had severe allergic reactions after using sodium heparin produced by the company, and 4 deaths were related to the quality and safety of heparin.

The active ingredients of all heparin products recalled by American bait are from the same supplier, the US SPL, while SPL, part of heparin sodium supplied by American bait, comes from its holding Jiangsu Changzhou CAPP biochemistry Co., Ltd.

After bait storm, in order to make up for the market gap, the US FDA agreed to approve the production of all standard high-dose standard heparin products under the premise of supplying heparin sodium APP raw material.

Happy passed the FDA review on the spot with "zero defect", and signed exclusive supply and exclusive purchase with APP company, so that Happy became the only supplier of high-dose standard heparin preparation in the US.

In 2008, Hai Pu Rui's operating income was 435 million yuan, and its profit was 190 million yuan. By 2009, its turnover increased to 2 billion 224 million yuan and net profit 809 million yuan.

It is precisely because of the soaring of 2009 that today's Hai Rui comes to the market and makes Li Li and his wife the myth of the new richest man in the mainland of China.